HBC Immunology shares promising results for prostate cancer co-therapy
There are around 55,100 new prostate cancer cases in the UK every year
Read More
Tag: HBC Immunology
- SolasCure trial shows faster healing with Aurase Wound Gel
- Gilead data show investigational HIV combination maintains viral suppression
- Verdiva Bio completes enrolment for phase 2b study of oral GLP‑1 candidate VRB‑101
- MHRA approves imlunestrant tosylate as new breast cancer treatment
- ACD440 granted orphan drug status in the EU
